Fig. 1From: Serum anti-phospholipase A2 receptor (PLA2R) antibody detected at diagnosis as a predictor for clinical remission in patients with primary membranous nephropathy: a meta-analysisFlow diagram for identification, screening, and inclusion of papers for this meta-analysisBack to article page